ResMed (RMD) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Magnificent 7 Earnings Out this Week will Shed Light on Big Tech’s Tariff ConcernsApril 23 at 7:44 AM | theglobeandmail.com2RMD : Assessing ResMed: Insights From 5 Financial AnalystsApril 21 at 8:43 PM | benzinga.comResMed price target lowered to $268 from $280 at KeyBancApril 21 at 3:42 PM | markets.businessinsider.comResMed price target lowered to $265 from $280 at MizuhoApril 16, 2025 | markets.businessinsider.comResmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Gets a Buy from Morgan StanleyApril 15, 2025 | markets.businessinsider.comResmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Gets a Buy from Goldman SachsApril 14, 2025 | markets.businessinsider.comEarnings Preview: What to Expect From ResMed’s ReportApril 14, 2025 | msn.comResMed placed on ‘downside 90-day catalyst watch’ at CitiApril 11, 2025 | markets.businessinsider.comResMed announces availability of home sleep apnea test NightOwlApril 3, 2025 | markets.businessinsider.comResMed (NYSE:RMD) Launches NightOwl Device to Simplify Home Sleep Apnea Testing Across USApril 3, 2025 | finance.yahoo.comResMed price target lowered to $280 from $290 at BofAApril 3, 2025 | markets.businessinsider.comJim Cramer is Discussing These 10 Stocks Ahead of Q1 Earnings SeasonApril 2, 2025 | insidermonkey.comIs ResMed Stock Outperforming the Dow?March 20, 2025 | msn.comGoldman Sachs Reaffirms Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)March 12, 2025 | markets.businessinsider.com2 ASX healthcare shares rated as top buysMarch 5, 2025 | fool.com.auResMed upgraded to Buy from Neutral at CitiMarch 5, 2025 | markets.businessinsider.comResMed price target lowered to $240 from $250 at StifelMarch 5, 2025 | markets.businessinsider.com2 Reasons to Like RMD and 1 to Stay SkepticalMarch 4, 2025 | msn.comThe ultimate ASX growth shares to buy with $2,000 in MarchMarch 4, 2025 | msn.comResMed Inc. (NYSE:RMD) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?February 24, 2025 | finance.yahoo.comWith 69% ownership, ResMed Inc. (NYSE:RMD) boasts of strong institutional backingFebruary 9, 2025 | finance.yahoo.comLooking to bag the record high ResMed dividend? You better hurry!February 5, 2025 | msn.comWilsons downgrades Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) to a HoldFebruary 3, 2025 | markets.businessinsider.comUBS upgrades Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) to a BuyFebruary 3, 2025 | markets.businessinsider.comResMed stock drops despite earnings beatFebruary 2, 2025 | msn.comResMed Insiders Sold US$17m Of Shares Suggesting HesitancyFebruary 2, 2025 | finance.yahoo.comResMed Tumbles As Organic Sales Growth Steps Down. Will These 'Mega Trends' Save It?January 31, 2025 | yahoo.comResmed (RMD) Receives a Hold from Stifel NicolausJanuary 31, 2025 | markets.businessinsider.comRBC lifts ResMed stock price target to $247 on strong 2Q performanceJanuary 31, 2025 | msn.comResMed (NYSE:RMD) Posts Better-Than-Expected Sales In Q4 But Stock DropsJanuary 31, 2025 | msn.comSleep device giant ResMed says Trump tariffs will boost profitsJanuary 31, 2025 | afr.com3RMD : Earnings Breakdown: ResMed Q2January 30, 2025 | benzinga.comResMed stock soars to 52-week high, reaching $260.71January 30, 2025 | msn.comJarden Keeps Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)January 29, 2025 | markets.businessinsider.comResMed Inc. (RMD) Stock ForecastsJanuary 28, 2025 | ca.finance.yahoo.comIf EPS Growth Is Important To You, ResMed (NYSE:RMD) Presents An OpportunityJanuary 26, 2025 | finance.yahoo.comResMed: Fully Valued With Medium-Term Challenges (Rating Downgrade)January 24, 2025 | seekingalpha.comBalanced Outlook on ResMed: Strong Execution and Innovations Offset by Valuation Concerns and Market ChallengesJanuary 10, 2025 | markets.businessinsider.comResMed initiated with a Neutral at Piper SandlerJanuary 10, 2025 | markets.businessinsider.comWall Street opens mixed as holiday-shortened week startsDecember 25, 2024 | usatoday.comIs ResMed Stock Outperforming the Nasdaq?December 17, 2024 | msn.comStifel Initiates Coverage of ResMed (RMD) with Hold RecommendationDecember 13, 2024 | msn.comResMed initiated with a Hold at StifelDecember 12, 2024 | markets.businessinsider.comResMed Inc. stock rises Wednesday, still underperforms marketDecember 11, 2024 | marketwatch.com'Huge opportunity' ahead for this ASX 200 healthcare stockDecember 10, 2024 | fool.com.auWhich insider sold $770,000 worth of ResMed shares this week?December 7, 2024 | msn.comHere's the outlook on ResMed shares in 2025December 6, 2024 | msn.comZacks Industry Outlook Highlights ResMed, Haemonetics, Phibro and AgiosDecember 5, 2024 | finance.yahoo.comInsider Activity Spotlight: Michael J Farrell Acquires In ResMed Stock OptionsNovember 28, 2024 | benzinga.comInsider Transaction: Michael J Farrell Sells $499K Worth Of ResMed SharesNovember 28, 2024 | benzinga.com Get ResMed News Delivered to You Automatically Sign up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter. Email Address RMD Media Mentions By Week RMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RMD News Sentiment▼-0.130.76▲Average Medical News Sentiment RMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RMD Articles This Week▼42▲RMD Articles Average Week Get ResMed News Delivered to You Automatically Sign up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GE HealthCare Technologies News Today Fresenius SE & Co. KGaA News Today Koninklijke Philips News Today Zimmer Biomet News Today Solventum News Today Smith & Nephew News Today Penumbra News Today Stevanato Group News Today Glaukos News Today Inari Medical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:RMD) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ResMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ResMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RMD Stock Free RMD Stock Alerts